{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:35:27Z","timestamp":1791394527735,"version":"4.3.3"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T00:00:00Z","timestamp":1471910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10741-016-9580-5","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T12:24:22Z","timestamp":1471955062000},"page":"703-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Recent advances in the noninvasive strategies of cardiac amyloidosis"],"prefix":"10.1007","volume":"21","author":[{"given":"Lei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"key":"9580_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01274-X","author":"AD Wechalekar","year":"2015","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN (2015) Systemic amyloidosis. The Lancet. doi: 10.1016\/S0140-6736(15)01274-X","journal-title":"The Lancet"},{"key":"9580_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13506129.2014.964858","volume":"21","author":"JD Sipe","year":"2014","unstructured":"Sipe JD, Benson MD, Buxbaum JN et al (2014) Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21:221\u2013224","journal-title":"Amyloid"},{"key":"9580_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14779072.2014.876363","volume":"12","author":"SW Yusuf","year":"2014","unstructured":"Yusuf SW, Solhpour A, Banchs J et al (2014) Cardiac amyloidosis. Expert Rev Cardiovasc Ther 12:265\u2013277","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"9580_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.carpath.2008.05.004","volume":"18","author":"AB Collins","year":"2009","unstructured":"Collins AB, Smith RN, Stone JR (2009) Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence. Cardiovasc Pathol 18:205\u2013216","journal-title":"Cardiovasc Pathol"},{"key":"9580_CR5","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","volume":"114","author":"JA Vrana","year":"2009","unstructured":"Vrana JA, Gamez JD, Madden BJ et al (2009) Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114:4957\u20134959","journal-title":"Blood"},{"key":"9580_CR6","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1073\/pnas.87.17.6542","volume":"87","author":"M Eulitz","year":"1990","unstructured":"Eulitz M, Weiss DT, Solomon A (1990) Immunoglobulin heavy-chain-associated amyloidosis. Proc Natl Acad Sci USA 87:6542\u20136546","journal-title":"Proc Natl Acad Sci USA"},{"key":"9580_CR7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM198709173171205","volume":"317","author":"LJ Olson","year":"1987","unstructured":"Olson LJ, Gertz MA, Edwards WD et al (1987) Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 317:738\u2013742","journal-title":"N Engl J Med"},{"key":"9580_CR8","doi-asserted-by":"crossref","first-page":"258471","DOI":"10.1155\/2014\/258471","volume":"2014","author":"L Millucci","year":"2014","unstructured":"Millucci L, Ghezzi L, Paccagnini E et al (2014) Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediat Inflamm 2014:258471","journal-title":"Mediat Inflamm"},{"key":"9580_CR9","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1053\/ajkd.1998.v31.pm10074578","volume":"31","author":"M Kawano","year":"1998","unstructured":"Kawano M, Muramoto H, Yamada M et al (1998) Fatal cardiac \u03b22-microglobulin amyloidosis in patients on long-term hemodialysis. Am J Kidney Dis 31:E4","journal-title":"Am J Kidney Dis"},{"key":"9580_CR10","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1046\/j.1523-1755.2001.59780172.x","volume":"Suppl 78","author":"F Takayama","year":"2001","unstructured":"Takayama F, Miyazaki S, Morita T et al (2001) Dialysis-related amyloidosis of the heart in long-term hemodialysis patients. Kidney Int Suppl 78:S172\u2013S176","journal-title":"Kidney Int"},{"key":"9580_CR11","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa1201356","volume":"366","author":"S Valleix","year":"2012","unstructured":"Valleix S, Gillmore JD, Bridoux F et al (2012) Hereditary systemic amyloidosis due to Asp76Asn variant \u03b22-microglobulin. N Engl J Med 366:2276\u20132283","journal-title":"N Engl J Med"},{"key":"9580_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9440(10)65268-6","volume":"154","author":"AL Hamidi","year":"1999","unstructured":"Hamidi AL, Liepnieks JJ, Hamidi AK et al (1999) Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 154:221\u2013227","journal-title":"Am J Pathol"},{"key":"9580_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1523-1755.2003.00047.x","volume":"64","author":"M Yazaki","year":"2003","unstructured":"Yazaki M, Liepnieks JJ, Barats MS et al (2003) Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. Kidney Int 64:11\u201316","journal-title":"Kidney Int"},{"key":"9580_CR14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/labinvest.3700124","volume":"84","author":"J Bergstrom","year":"2004","unstructured":"Bergstrom J, Murphy CL, Weiss DT et al (2004) Two different types of amyloid deposits\u2014apolipoprotein A-IV and transthyretin\u2014in a patient with systemic amyloidosis. Lab Investig 84:981\u2013988","journal-title":"Lab Investig"},{"key":"9580_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0925-4439(90)90016-I","volume":"1096","author":"CP Maury","year":"1990","unstructured":"Maury CP, Baumann M (1990) Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1096:84\u201386","journal-title":"Biochim Biophys Acta"},{"key":"9580_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.carpath.2006.01.005","volume":"15","author":"I Steiner","year":"2006","unstructured":"Steiner I, Hajkova P (2006) Patterns of isolated atrial amyloid: a study of 100 hearts on autopsy. Cardiovasc Pathol 15:287\u2013290","journal-title":"Cardiovasc Pathol"},{"key":"9580_CR17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","volume":"24","author":"JJ Maleszewski","year":"2015","unstructured":"Maleszewski JJ (2015) Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol 24:343\u2013350","journal-title":"Cardiovasc Pathol"},{"key":"9580_CR18","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1586\/14779072.2015.1093936","volume":"13","author":"G Palladini","year":"2015","unstructured":"Palladini G, Milani P, Merlini G (2015) Novel strategies for the diagnosis and treatment of cardiac amyloidosis. Expert Rev Cardiovasc Ther 13:1195\u20131211","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"9580_CR19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.acvd.2013.06.051","volume":"106","author":"D Mohty","year":"2013","unstructured":"Mohty D, Damy T, Cosnay P et al (2013) Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis 106:528\u2013540","journal-title":"Arch Cardiovasc Dis"},{"key":"9580_CR20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12383","volume":"278","author":"KS Patel","year":"2015","unstructured":"Patel KS, Hawkins PN (2015) Cardiac amyloidosis: where are we today? J Intern Med 278:126\u2013144","journal-title":"J Intern Med"},{"key":"9580_CR21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1586\/14779072.2015.1069181","volume":"13","author":"TV Kourelis","year":"2015","unstructured":"Kourelis TV, Gertz MA (2015) Improving strategies for the diagnosis of cardiac amyloidosis. Expert Rev Cardiovasc Ther 13:945\u2013961","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"9580_CR22","first-page":"45","volume":"32","author":"RA Kyle","year":"1995","unstructured":"Kyle RA, Gertz MA (1995) Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 32:45\u201359","journal-title":"Semin Hematol"},{"key":"9580_CR23","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","volume":"79","author":"RA Kyle","year":"1992","unstructured":"Kyle RA, Linos A, Beard CM et al (1992) Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 79:1817\u20131822","journal-title":"Blood"},{"key":"9580_CR24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bjh.12286","volume":"161","author":"JH Pinney","year":"2013","unstructured":"Pinney JH, Smith CJ, Taube JB et al (2013) Systemic amyloidosis in England: an epidemiological study. Br J Haematol 161:525\u2013532","journal-title":"Br J Haematol"},{"key":"9580_CR25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ajh.23898","volume":"90","author":"GP Kaufman","year":"2015","unstructured":"Kaufman GP, Dispenzieri A, Gertz MA et al (2015) Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis. Am J Hematol 90:181\u2013186","journal-title":"Am J Hematol"},{"key":"9580_CR26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/ajh.23827","volume":"89","author":"TV Kourelis","year":"2014","unstructured":"Kourelis TV, Kumar SK, Go RS et al (2014) Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias. Am J Hematol 89:1051\u20131054","journal-title":"Am J Hematol"},{"key":"9580_CR27","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2013.50.8499","volume":"31","author":"TV Kourelis","year":"2013","unstructured":"Kourelis TV, Kumar SK, Gertz MA et al (2013) Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis. J Clin Oncol 31:4319\u20134324","journal-title":"J Clin Oncol"},{"key":"9580_CR28","doi-asserted-by":"crossref","first-page":"e137716","DOI":"10.1371\/journal.pone.0137716","volume":"10","author":"HP McWilliams-Koeppen","year":"2015","unstructured":"McWilliams-Koeppen HP, Foster JS, Hackenbrack N et al (2015) Light chain amyloid fibrils cause metabolic dysfunction in human cardiomyocytes. PLoS ONE 10:e137716","journal-title":"PLoS ONE"},{"key":"9580_CR29","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1096\/fj.15-272179","volume":"29","author":"F Lavatelli","year":"2015","unstructured":"Lavatelli F, Imperlini E, Orru S et al (2015) Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis. FASEB J 29:4614\u20134628","journal-title":"FASEB J"},{"key":"9580_CR30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00395-013-0378-5","volume":"108","author":"J Guan","year":"2013","unstructured":"Guan J, Mishra S, Shi J et al (2013) Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol 108:378","journal-title":"Basic Res Cardiol"},{"key":"9580_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.carpath.2006.09.011","volume":"16","author":"CM Wittich","year":"2007","unstructured":"Wittich CM, Neben-Wittich MA, Mueller PS et al (2007) Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis. Cardiovasc Pathol 16:75\u201378","journal-title":"Cardiovasc Pathol"},{"key":"9580_CR32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","volume":"2","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Vangala D, Bruyere JJ et al (2014) Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail 2:358\u2013367","journal-title":"JACC Heart Fail"},{"key":"9580_CR33","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1038\/cddis.2010.75","volume":"1","author":"LA Sikkink","year":"2010","unstructured":"Sikkink LA, Ramirez-Alvarado M (2010) Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture. Cell Death Dis 1:e98","journal-title":"Cell Death Dis"},{"key":"9580_CR34","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","volume":"107","author":"J Shi","year":"2010","unstructured":"Shi J, Guan J, Jiang B et al (2010) Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38 MAPK pathway. Proc Natl Acad Sci 107:4188\u20134193","journal-title":"Proc Natl Acad Sci"},{"key":"9580_CR35","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","volume":"94","author":"DA Brenner","year":"2004","unstructured":"Brenner DA, Jain M, Pimentel DR et al (2004) Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 94:1008\u20131010","journal-title":"Circ Res"},{"key":"9580_CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2009.04.044","volume":"145","author":"RQ Migrino","year":"2010","unstructured":"Migrino RQ, Hari P, Gutterman DD et al (2010) Systemic and microvascular oxidative stress induced by light chain amyloidosis. Int J Cardiol 145:67\u201368","journal-title":"Int J Cardiol"},{"key":"9580_CR37","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1182\/blood-2013-10-525634","volume":"123","author":"L Diomede","year":"2014","unstructured":"Diomede L, Rognoni P, Lavatelli F et al (2014) A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis. Blood 123:3543\u20133552","journal-title":"Blood"},{"key":"9580_CR38","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.15252\/emmm.201404190","volume":"6","author":"J Guan","year":"2014","unstructured":"Guan J, Mishra S, Qiu Y et al (2014) Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med 6:1493\u20131507","journal-title":"EMBO Mol Med"},{"key":"9580_CR39","doi-asserted-by":"crossref","first-page":"13046","DOI":"10.1073\/pnas.1406050111","volume":"111","author":"CB Cooley","year":"2014","unstructured":"Cooley CB, Ryno LM, Plate L et al (2014) Unfolded protein response activation reduces secretion and extracellular aggregation of amyloidogenic immunoglobulin light chain. Proc Natl Acad Sci USA 111:13046\u201313051","journal-title":"Proc Natl Acad Sci USA"},{"key":"9580_CR40","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg FL, Berk JL (2012) Transthyretin (TTR) cardiac amyloidosis. Circulation 126:1286\u20131300","journal-title":"Circulation"},{"key":"9580_CR41","first-page":"39","volume":"8","author":"VK Ton","year":"2014","unstructured":"Ton VK, Mukherjee M, Judge DP (2014) Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction. Clin Med Insights Cardiol 8:39\u201344","journal-title":"Clin Med Insights Cardiol"},{"key":"9580_CR42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/postgradmedj-2014-133224","volume":"91","author":"S Dubrey","year":"2015","unstructured":"Dubrey S, Ackermann E, Gillmore J (2015) The transthyretin amyloidoses: advances in therapy. Postgrad Med J 91:439\u2013448","journal-title":"Postgrad Med J"},{"issue":"Suppl 1","key":"9580_CR43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13506129.2012.665400","volume":"19","author":"SR Zeldenrust","year":"2012","unstructured":"Zeldenrust SR (2012) Genotype\u2013phenotype correlation in FAP. Amyloid 19(Suppl 1):22\u201324","journal-title":"Amyloid"},{"key":"9580_CR44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1107\/S090744491104491X","volume":"67","author":"AF Castro-Rodrigues","year":"2011","unstructured":"Castro-Rodrigues AF, Gales L, Saraiva MJ et al (2011) Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils. Acta Crystallogr D Biol Crystallogr 67:1035\u20131044","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"9580_CR45","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","volume":"161","author":"MM Sousa","year":"2002","unstructured":"Sousa MM, Fernandes R, Palha JA et al (2002) Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am J Pathol 161:1935\u20131948","journal-title":"Am J Pathol"},{"key":"9580_CR46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00220559","volume":"89","author":"DR Jacobson","year":"1992","unstructured":"Jacobson DR, McFarlin DE, Kane I et al (1992) Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet 89:353\u2013356","journal-title":"Hum Genet"},{"key":"9580_CR47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jns.2016.01.046","volume":"362","author":"A Yukio","year":"2016","unstructured":"Yukio A, Yoshiki S, Konen O et al (2016) Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Varl30Met: a phase III, open-label study. J Neurol Sci 362:266\u2013271","journal-title":"J Neurol Sci"},{"key":"9580_CR48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1212\/WNL.0000000000001870","volume":"85","author":"D Adams","year":"2015","unstructured":"Adams D, Coelho T, Obici L et al (2015) Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study. Neurology 85:675\u2013682","journal-title":"Neurology"},{"key":"9580_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13506120500107162","volume":"12","author":"T Yamashita","year":"2005","unstructured":"Yamashita T, Hamidi AK, Yazaki M et al (2005) A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population. Amyloid 12:127\u2013130","journal-title":"Amyloid"},{"key":"9580_CR50","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2010.02.006","volume":"159","author":"J Buxbaum","year":"2010","unstructured":"Buxbaum J, Alexander A, Koziol J et al (2010) Significance of the amyloidogenic transthyretin Val122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Am Heart J 159:864\u2013870","journal-title":"Am Heart J"},{"key":"9580_CR51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ahj.2012.04.015","volume":"164","author":"FL Ruberg","year":"2012","unstructured":"Ruberg FL, Maurer MS, Judge DP et al (2012) Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J 164:222\u2013228","journal-title":"Am Heart J"},{"key":"9580_CR52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","volume":"372","author":"CC Quarta","year":"2015","unstructured":"Quarta CC, Buxbaum JN, Shah AM et al (2015) The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med 372:21\u201329","journal-title":"N Engl J Med"},{"key":"9580_CR53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.ejhg.5201095","volume":"12","author":"ML Soares","year":"2004","unstructured":"Soares ML, Coelho T, Sousa A et al (2004) Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden. Eur J Hum Genet 12:225\u2013237","journal-title":"Eur J Hum Genet"},{"key":"9580_CR54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/B978-0-444-52902-2.00038-2","volume":"115","author":"V Plante-Bordeneuve","year":"2013","unstructured":"Plante-Bordeneuve V, Kerschen P (2013) Transthyretin familial amyloid polyneuropathy. Handb Clin Neurol 115:643\u2013658","journal-title":"Handb Clin Neurol"},{"key":"9580_CR55","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrcardio.2010.67","volume":"7","author":"C Rapezzi","year":"2010","unstructured":"Rapezzi C, Quarta CC, Riva L et al (2010) Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 7:398\u2013408","journal-title":"Nat Rev Cardiol"},{"key":"9580_CR56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ajpath.2010.11.015","volume":"178","author":"MJ Greene","year":"2011","unstructured":"Greene MJ, Sam F, Soo HP et al (2011) Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy. Am J Pathol 178:61\u201368","journal-title":"Am J Pathol"},{"key":"9580_CR57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jmb.2005.11.051","volume":"356","author":"K Sorgjerd","year":"2006","unstructured":"Sorgjerd K, Ghafouri B, Jonsson BH et al (2006) Retention of misfolded mutant transthyretin by the chaperone BiP\/GRP78 mitigates amyloidogenesis. J Mol Biol 356:469\u2013482","journal-title":"J Mol Biol"},{"key":"9580_CR58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/labinvest.3780116","volume":"80","author":"MM Sousa","year":"2000","unstructured":"Sousa MM, Yan SD, Stern D et al (2000) Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Investig 80:1101\u20131110","journal-title":"Lab Investig"},{"key":"9580_CR59","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","volume":"106","author":"SF Yan","year":"2010","unstructured":"Yan SF, Ramasamy R, Schmidt AM (2010) The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 106:842\u2013853","journal-title":"Circ Res"},{"key":"9580_CR60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCHEARTFAILURE.108.788687","volume":"1","author":"A Biolo","year":"2008","unstructured":"Biolo A, Ramamurthy S, Connors LH et al (2008) Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Circ Heart Fail 1:249\u2013257","journal-title":"Circ Heart Fail"},{"key":"9580_CR61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/hrt.27.5.711","volume":"27","author":"A Pomerance","year":"1965","unstructured":"Pomerance A (1965) Senile cardiac amyloidosis. Br Heart J 27:711\u2013718","journal-title":"Br Heart J"},{"key":"9580_CR62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","volume":"2","author":"SF Mohammed","year":"2014","unstructured":"Mohammed SF, Mirzoyev SA, Edwards WD et al (2014) Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2:113\u2013122","journal-title":"JACC Heart Fail"},{"key":"9580_CR63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-008-9841-2","volume":"317","author":"I Goncalves","year":"2008","unstructured":"Goncalves I, Alves CH, Quintela T et al (2008) Transthyretin is up-regulated by sex hormones in mice liver. Mol Cell Biochem 317:137\u2013142","journal-title":"Mol Cell Biochem"},{"key":"9580_CR64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.11687","volume":"93","author":"T Bochtler","year":"2008","unstructured":"Bochtler T, Hegenbart U, Heiss C et al (2008) Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis. Haematologica 93:459\u2013462","journal-title":"Haematologica"},{"key":"9580_CR65","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","volume":"30","author":"G Palladini","year":"2012","unstructured":"Palladini G, Dispenzieri A, Gertz MA et al (2012) New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol 30:4541\u20134549","journal-title":"J Clin Oncol"},{"key":"9580_CR66","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ajh.23828","volume":"89","author":"MA Gertz","year":"2014","unstructured":"Gertz MA (2014) Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment. Am J Hematol 89:1132\u20131140","journal-title":"Am J Hematol"},{"key":"9580_CR67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/13506129.2013.844122","volume":"20","author":"H Usuku","year":"2013","unstructured":"Usuku H, Obayashi K, Shono M et al (2013) Usefulness of plasma B-type natriuretic peptide as a prognostic marker of cardiac function in senile systemic amyloidosis and in familial amyloidotic polyneuropathy. Amyloid 20:251\u2013255","journal-title":"Amyloid"},{"key":"9580_CR68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/13506120903421538","volume":"16","author":"S Lehrke","year":"2009","unstructured":"Lehrke S, Steen H, Kristen AV et al (2009) Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis. Amyloid 16:187\u2013195","journal-title":"Amyloid"},{"key":"9580_CR69","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","volume":"107","author":"G Palladini","year":"2003","unstructured":"Palladini G, Campana C, Klersy C et al (2003) Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 107:2440\u20132445","journal-title":"Circulation"},{"key":"9580_CR70","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.amjcard.2012.05.061","volume":"110","author":"T Apridonidze","year":"2012","unstructured":"Apridonidze T, Steingart RM, Comenzo RL et al (2012) Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis. Am J Cardiol 110:1180\u20131184","journal-title":"Am J Cardiol"},{"key":"9580_CR71","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ et al (2012) Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 30:989\u2013995","journal-title":"J Clin Oncol"},{"key":"9580_CR72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/anec.12018","volume":"18","author":"Z Cheng","year":"2013","unstructured":"Cheng Z, Zhu K, Tian Z et al (2013) The findings of electrocardiography in patients with cardiac amyloidosis. Ann Noninvasive Electrocardiol 18:157\u2013162","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"9580_CR73","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2003.08.043","volume":"43","author":"JE Rahman","year":"2004","unstructured":"Rahman JE, Helou EF, Gelzer-Bell R et al (2004) Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 43:410\u2013415","journal-title":"J Am Coll Cardiol"},{"key":"9580_CR74","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","volume":"114","author":"NB Cyrille","year":"2014","unstructured":"Cyrille NB, Goldsmith J, Alvarez J et al (2014) Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis. Am J Cardiol 114:1089\u20131093","journal-title":"Am J Cardiol"},{"key":"9580_CR75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/anec.12036","volume":"18","author":"R Mussinelli","year":"2013","unstructured":"Mussinelli R, Salinaro F, Alogna A et al (2013) Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis. Ann Noninvasive Electrocardiol 18:271\u2013280","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"9580_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2015.11.004","author":"L Zhao","year":"2015","unstructured":"Zhao L, Li J, Tian Z et al (2015) Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis. J Cardiol. doi: 10.1016\/j.jjcc.2015.11.004","journal-title":"J Cardiol"},{"key":"9580_CR77","first-page":"1281","volume":"118","author":"MA Neben-Wittich","year":"2005","unstructured":"Neben-Wittich MA, Wittich CM, Mueller PS et al (2005) Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. Am J Med 118:1281\u20131287","journal-title":"Am J Med"},{"key":"9580_CR78","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/anec.12032","volume":"18","author":"M Boldrini","year":"2013","unstructured":"Boldrini M, Salinaro F, Mussinelli R et al (2013) Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis. Ann Noninvasive Electrocardiol 18:327\u2013335","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"9580_CR79","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","volume":"120","author":"C Rapezzi","year":"2009","unstructured":"Rapezzi C, Merlini G, Quarta CC et al (2009) Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120:1203\u20131212","journal-title":"Circulation"},{"key":"9580_CR80","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.ijcard.2012.05.097","volume":"167","author":"S Perlini","year":"2013","unstructured":"Perlini S, Salinaro F, Cappelli F et al (2013) Prognostic value of fragmented QRS in cardiac AL amyloidosis. Int J Cardiol 167:2156\u20132161","journal-title":"Int J Cardiol"},{"key":"9580_CR81","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000177950","volume":"113","author":"V Ariyarajah","year":"2009","unstructured":"Ariyarajah V, Steiner I, Hajkova P et al (2009) The association of atrial tachyarrhythmias with isolated atrial amyloid disease: preliminary observations in autopsied heart specimens. Cardiology 113:132\u2013137","journal-title":"Cardiology"},{"key":"9580_CR82","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","volume":"22","author":"S Longhi","year":"2015","unstructured":"Longhi S, Quarta CC, Milandri A et al (2015) Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid 22:147\u2013155","journal-title":"Amyloid"},{"key":"9580_CR83","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/euhj.2001.2972","volume":"23","author":"AK Reyners","year":"2002","unstructured":"Reyners AK, Hazenberg BP, Reitsma WD et al (2002) Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis. Eur Heart J 23:157\u2013161","journal-title":"Eur Heart J"},{"key":"9580_CR84","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","volume":"13","author":"CR Barbhaiya","year":"2016","unstructured":"Barbhaiya CR, Kumar S, Baldinger SH et al (2016) Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy. Heart Rhythm 13:383\u2013390","journal-title":"Heart Rhythm"},{"key":"9580_CR85","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0002-9149(75)90891-7","volume":"36","author":"C Chew","year":"1975","unstructured":"Chew C, Ziady GM, Raphael MJ et al (1975) The functional defect in amyloid heart disease. The \u201cstiff heart\u201d syndrome. Am J Cardiol 36:438\u2013444","journal-title":"Am J Cardiol"},{"key":"9580_CR86","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.66.4.790","volume":"66","author":"JSM St","year":"1982","unstructured":"St JSM, Reichek N, Kastor JA et al (1982) Computerized M-mode echocardiographic analysis of left ventricular dysfunction in cardiac amyloid. Circulation 66:790\u2013799","journal-title":"Circulation"},{"key":"9580_CR87","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1253\/circj.CJ-14-1425","volume":"79","author":"J Koyama","year":"2015","unstructured":"Koyama J, Ikeda S, Ikeda U (2015) Echocardiographic assessment of the cardiac amyloidoses. Circ J 79:721\u2013734","journal-title":"Circ J"},{"key":"9580_CR88","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ehjci\/jeu158","volume":"15","author":"G Bella Di","year":"2014","unstructured":"Di Bella G, Pizzino F, Minutoli F et al (2014) The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. Eur Heart J Cardiovasc Imaging 15:1307\u20131315","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9580_CR89","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/JAHA.111.000364","volume":"1","author":"SM Banypersad","year":"2012","unstructured":"Banypersad SM, Moon JC, Whelan C et al (2012) Updates in cardiac amyloidosis: a review. J Am Heart Assoc 1:e364","journal-title":"J Am Heart Assoc"},{"key":"9580_CR90","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH et al (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis, tours, france, 18\u201322 April 2004. Am J Hematol 79:319\u2013328","journal-title":"Am J Hematol"},{"key":"9580_CR91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9149(82)90270-3","volume":"49","author":"JD Carroll","year":"1982","unstructured":"Carroll JD, Gaasch WH, McAdam KP (1982) Amyloid cardiomyopathy: characterization by a distinctive voltage\/mass relation. Am J Cardiol 49:9\u201313","journal-title":"Am J Cardiol"},{"key":"9580_CR92","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9149(87)90948-9","volume":"59","author":"RH Falk","year":"1987","unstructured":"Falk RH, Plehn JF, Deering T et al (1987) Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 59:418\u2013422","journal-title":"Am J Cardiol"},{"key":"9580_CR93","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.amjms.2015.12.015","volume":"351","author":"L Zhao","year":"2016","unstructured":"Zhao L, Tian Z, Fang Q (2016) Risk factors and prognostic role of left atrial enlargement in patients with cardiac light-chain amyloidosis. Am J Med Sci 351:271\u2013278","journal-title":"Am J Med Sci"},{"key":"9580_CR94","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.mayocp.2014.01.013","volume":"89","author":"GY Lee","year":"2014","unstructured":"Lee GY, Kim K, Choi J et al (2014) Cardiac amyloidosis without increased left ventricular wall thickness. Mayo Clin Proc 89:781\u2013789","journal-title":"Mayo Clin Proc"},{"key":"9580_CR95","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.echo.2013.12.010","volume":"27","author":"R Suresh","year":"2014","unstructured":"Suresh R, Grogan M, Maleszewski JJ et al (2014) Advanced cardiac amyloidosis associated with\u00a0normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr 27:440\u2013447","journal-title":"J Am Soc Echocardiogr"},{"key":"9580_CR96","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0735-1097(96)00202-1","volume":"28","author":"C Tei","year":"1996","unstructured":"Tei C, Dujardin KS, Hodge DO et al (1996) Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 28:658\u2013664","journal-title":"J Am Coll Cardiol"},{"key":"9580_CR97","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13506120902879681","volume":"16","author":"MC Porciani","year":"2009","unstructured":"Porciani MC, Lilli A, Perfetto F et al (2009) Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid 16:63\u201370","journal-title":"Amyloid"},{"key":"9580_CR98","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.amjcard.2004.04.026","volume":"94","author":"J Ha","year":"2004","unstructured":"Ha J, Ommen SR, Tajik AJ et al (2004) Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. Am J Cardiol 94:316\u2013319","journal-title":"Am J Cardiol"},{"key":"9580_CR99","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1586\/14779072.2015.1056163","volume":"13","author":"P Pokharel","year":"2015","unstructured":"Pokharel P, Fujikura K, Bella JN (2015) Clinical applications and prognostic implications of strain and strain rate imaging. Expert Rev Cardiovasc Ther 13:853\u2013866","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"9580_CR100","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","volume":"107","author":"J Koyama","year":"2003","unstructured":"Koyama J, Ray-Sequin PA, Falk RH (2003) Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107:2446\u20132452","journal-title":"Circulation"},{"key":"9580_CR101","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","volume":"3","author":"J Koyama","year":"2010","unstructured":"Koyama J, Falk RH (2010) Prognostic significance of strain doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 3:333\u2013342","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR102","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ehjci\/jes009","volume":"13","author":"D Bellavia","year":"2012","unstructured":"Bellavia D, Pellikka PA, Dispenzieri A et al (2012) Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study. Eur Heart J Cardiovasc Imaging 13:680\u2013689","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9580_CR103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12574-015-0249-1","volume":"13","author":"F Cacciapuoti","year":"2015","unstructured":"Cacciapuoti F (2015) The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. J Echocardiogr 13:84\u201389","journal-title":"J Echocardiogr"},{"key":"9580_CR104","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/echo.12969","volume":"32","author":"H Huang","year":"2015","unstructured":"Huang H, Jing X, Hu Z et al (2015) Early impairment of cardiac function and asynchronization of systemic amyloidosis with preserved ejection fraction using two-dimensional speckle tracking echocardiography. Echocardiography 32:1832\u20131840","journal-title":"Echocardiography"},{"key":"9580_CR105","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","volume":"129","author":"CC Quarta","year":"2014","unstructured":"Quarta CC, Solomon SD, Uraizee I et al (2014) Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation 129:1840\u20131849","journal-title":"Circulation"},{"key":"9580_CR106","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.recesp.2015.01.011","volume":"68","author":"JA Urbano-Moral","year":"2015","unstructured":"Urbano-Moral JA, Gangadharamurthy D, Comenzo RL et al (2015) Three-dimensional speckle tracking echocardiography in light chain cardiac amyloidosis: examination of left and right ventricular myocardial mechanics parameters. Revista Espa\u00f1ola de Cardiolog\u00eda 68:657\u2013664 (English Edition)","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"key":"9580_CR107","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.amjcard.2008.09.102","volume":"103","author":"JP Sun","year":"2009","unstructured":"Sun JP, Stewart WJ, Yang XS et al (2009) Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol 103:411\u2013415","journal-title":"Am J Cardiol"},{"key":"9580_CR108","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P et al (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98:1442\u20131448","journal-title":"Heart"},{"key":"9580_CR109","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","volume":"102","author":"A Senapati","year":"2016","unstructured":"Senapati A, Sperry BW, Grodin JL et al (2016) Prognostic implication of relative regional strain ratio in cardiac amyloidosis. Heart 102:748\u2013754","journal-title":"Heart"},{"key":"9580_CR110","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","volume":"60","author":"SJ Buss","year":"2012","unstructured":"Buss SJ, Emami M, Mereles D et al (2012) Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol 60:1067\u20131076","journal-title":"J Am Coll Cardiol"},{"key":"9580_CR111","doi-asserted-by":"crossref","first-page":"e56923","DOI":"10.1371\/journal.pone.0056923","volume":"8","author":"D Liu","year":"2013","unstructured":"Liu D, Hu K, Niemann M et al (2013) Impact of regional left ventricular function on outcome for patients with AL amyloidosis. PLoS ONE 8:e56923","journal-title":"PLoS ONE"},{"key":"9580_CR112","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-014-9470-7","volume":"20","author":"M Fontana","year":"2015","unstructured":"Fontana M, Chung R, Hawkins PN et al (2015) Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev 20:133\u2013144","journal-title":"Heart Fail Rev"},{"key":"9580_CR113","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12968-016-0240-7","volume":"18","author":"R Li","year":"2016","unstructured":"Li R, Yang Z, Wen L et al (2016) Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance. J Cardiovasc Magn Reson 18:16","journal-title":"J Cardiovasc Magn Reson"},{"key":"9580_CR114","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","volume":"3","author":"IS Syed","year":"2010","unstructured":"Syed IS, Glockner JF, Feng D et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3:155\u2013164","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR115","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","volume":"51","author":"H Vogelsberg","year":"2008","unstructured":"Vogelsberg H, Mahrholdt H, Deluigi CC et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis. J Am Coll Cardiol 51:1022\u20131030","journal-title":"J Am Coll Cardiol"},{"key":"9580_CR116","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjcard.2008.09.105","volume":"103","author":"FL Ruberg","year":"2009","unstructured":"Ruberg FL, Appelbaum E, Davidoff R et al (2009) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103:544\u2013549","journal-title":"Am J Cardiol"},{"key":"9580_CR117","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10554-014-0436-6","volume":"30","author":"GD Aquaro","year":"2014","unstructured":"Aquaro GD, Pugliese NR, Perfetto F et al (2014) Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis. Int J Cardiovasc Imaging 30:1105\u20131115","journal-title":"Int J Cardiovasc Imaging"},{"key":"9580_CR118","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1586\/14779072.2014.986098","volume":"12","author":"AN Bhuva","year":"2014","unstructured":"Bhuva AN, Treibel TA, Fontana M et al (2014) T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance. Expert Rev Cardiovasc Ther 12:1455\u20131464","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"9580_CR119","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM et al (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6:488\u2013497","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","volume":"7","author":"M Fontana","year":"2014","unstructured":"Fontana M, Banypersad SM, Treibel TA et al (2014) Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7:157\u2013165","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR121","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/RLI.0b013e318059e021","volume":"42","author":"W Hosch","year":"2007","unstructured":"Hosch W, Bock M, Libicher M et al (2007) MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis. Investig Radiol 42:636\u2013642","journal-title":"Investig Radiol"},{"key":"9580_CR122","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","volume":"6","author":"SM Banypersad","year":"2013","unstructured":"Banypersad SM, Sado DM, Flett AS et al (2013) Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 6:34\u201339","journal-title":"Circ Cardiovasc Imaging"},{"key":"9580_CR123","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jcmg.2012.04.006","volume":"5","author":"FP Mongeon","year":"2012","unstructured":"Mongeon FP, Jerosch-Herold M, Coelho-Filho OR et al (2012) Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging 5:897\u2013907","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR124","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","volume":"277","author":"M Fontana","year":"2015","unstructured":"Fontana M, Banypersad SM, Treibel TA et al (2015) Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study. Radiology 277:388\u2013397","journal-title":"Radiology"},{"key":"9580_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.10.027","author":"SJ Boynton","year":"2016","unstructured":"Boynton SJ, Geske JB, Dispenzieri A et al (2016) LGE provides incremental prognostic information over serum biomarkers in AL cardiac amyloidosis. JACC Cardiovasc Imaging. doi: 10.1016\/j.jcmg.2015.10.027","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR126","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132:1570\u20131579","journal-title":"Circulation"},{"key":"9580_CR127","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","volume":"36","author":"SM Banypersad","year":"2015","unstructured":"Banypersad SM, Fontana M, Maestrini V et al (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36:244\u2013251","journal-title":"Eur Heart J"},{"key":"9580_CR128","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcmg.2015.11.002","volume":"9","author":"AA Kammerlander","year":"2016","unstructured":"Kammerlander AA, Marzluf BA, Zotter-Tufaro C et al (2016) T1 mapping by CMR imaging: from histological validation to clinical implication. JACC Cardiovasc Imaging 9:14\u201323","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13506129.2015.1020153","volume":"22","author":"AV Kristen","year":"2014","unstructured":"Kristen AV, Aus Dem Siepen F, Scherer K et al (2014) Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging. Amyloid 22:132\u2013141","journal-title":"Amyloid"},{"key":"9580_CR130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","volume":"21","author":"S Bokhari","year":"2014","unstructured":"Bokhari S, Shahzad R, Casta\u00f1o A et al (2014) Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol 21:175\u2013184","journal-title":"J Nucl Cardiol"},{"key":"9580_CR131","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2011.06.123","volume":"164","author":"AV Kristen","year":"2013","unstructured":"Kristen AV, Haufe S, Schonland SO et al (2013) Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis. Int J Cardiol 164:179\u2013184","journal-title":"Int J Cardiol"},{"key":"9580_CR132","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F et al (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46:1076\u20131084","journal-title":"J Am Coll Cardiol"},{"key":"9580_CR133","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","volume":"4","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL et al (2011) Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging 4:659\u2013670","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR134","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","volume":"15","author":"DF Hutt","year":"2014","unstructured":"Hutt DF, Quigley AM, Page J et al (2014) Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging 15:1289\u20131298","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9580_CR135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s12149-012-0627-y","volume":"26","author":"Y Yamamoto","year":"2012","unstructured":"Yamamoto Y, Onoguchi M, Haramoto M et al (2012) Novel method for quantitative evaluation of cardiac amyloidosis using 201TlCl and 99mTc-PYP SPECT. Ann Nucl Med 26:634\u2013643","journal-title":"Ann Nucl Med"},{"key":"9580_CR136","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","volume":"6","author":"S Bokhari","year":"2013","unstructured":"Bokhari S, Castano A, Pozniakoff T et al (2013) 99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 6:195\u2013201","journal-title":"Circ Cardiovasc Imaging"},{"key":"9580_CR137","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-015-0261-x","author":"A Casta\u00f1o","year":"2015","unstructured":"Casta\u00f1o A, DeLuca A, Weinberg R et al (2015) Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis. J Nucl Cardiol. doi: 10.1007\/s12350-015-0261-x","journal-title":"J Nucl Cardiol"},{"key":"9580_CR138","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-016-0478-3","author":"SC Harb","year":"2016","unstructured":"Harb SC, Haq M, Flood K et al (2016) National patterns in imaging utilization for diagnosis of cardiac amyloidosis: a focus on Tc99m-pyrophosphate scintigraphy. J Nucl Cardiol. doi: 10.1007\/s12350-016-0478-3","journal-title":"J Nucl Cardiol"},{"key":"9580_CR139","first-page":"1040","volume":"36","author":"T Nakata","year":"1995","unstructured":"Nakata T, Shimamoto K, Yonekura S et al (1995) Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG. J Nucl Med 36:1040\u20131042","journal-title":"J Nucl Med"},{"key":"9580_CR140","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00259-012-2187-8","volume":"39","author":"W Noordzij","year":"2012","unstructured":"Noordzij W, Glaudemans AWJM et al (2012) 123I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis. Eur J Nucl Med Mol I 39:1609\u20131617","journal-title":"Eur J Nucl Med Mol I"},{"key":"9580_CR141","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0735-1097(96)00438-X","volume":"29","author":"M Tanaka","year":"1997","unstructured":"Tanaka M, Hongo M, Kinoshita O et al (1997) Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol 29:168\u2013174","journal-title":"J Am Coll Cardiol"},{"key":"9580_CR142","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","volume":"6","author":"MCA Coutinho","year":"2013","unstructured":"Coutinho MCA, Cortez-Dias N, Cantinho G et al (2013) Reduced myocardial 123-Iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging 6:627\u2013636","journal-title":"Circ Cardiovasc Imaging"},{"key":"9580_CR143","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jns.2014.07.017","volume":"345","author":"R Takahashi","year":"2014","unstructured":"Takahashi R, Ono K, Shibata S et al (2014) Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area. J Neurol Sci 345:231\u2013235","journal-title":"J Neurol Sci"},{"key":"9580_CR144","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1067\/mhj.2002.123115","volume":"144","author":"M Hongo","year":"2002","unstructured":"Hongo M, Urushibata K, Kai R et al (2002) Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Am Heart J 144:122\u2013129","journal-title":"Am Heart J"},{"key":"9580_CR145","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF01791147","volume":"22","author":"C Aprile","year":"1995","unstructured":"Aprile C, Marinone G, Saponaro R et al (1995) Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin. Eur J Nucl Med 22:1393\u20131401","journal-title":"Eur J Nucl Med"},{"key":"9580_CR146","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0609.2007.00963.x","volume":"79","author":"S Han","year":"2007","unstructured":"Han S, Chong V, Murray T et al (2007) Preliminary experience of 99mTc\u2010aprotinin scintigraphy in amyloidosis. Eur J Haematol 79:494\u2013500","journal-title":"Eur J Haematol"},{"key":"9580_CR147","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/13506129.2014.973105","volume":"21","author":"D Rowczenio","year":"2014","unstructured":"Rowczenio D, Tennent GA, Gilbertson J et al (2014) Clinical characteristics and SAP scintigraphic findings in 10 patients with AGel amyloidosis. Amyloid 21:276\u2013281","journal-title":"Amyloid"},{"key":"9580_CR148","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","volume":"373","author":"DB Richards","year":"2015","unstructured":"Richards DB, Cookson LM, Berges AC et al (2015) Therapeutic clearance of amyloid by antibodies to serum amyloid P component. New Engl J Med 373:1106\u20131114","journal-title":"New Engl J Med"},{"key":"9580_CR149","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","volume":"54","author":"G Antoni","year":"2013","unstructured":"Antoni G, Lubberink M, Estrada S et al (2013) In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med 54:213\u2013220","journal-title":"J Nucl Med"},{"key":"9580_CR150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","volume":"8","author":"SP Lee","year":"2015","unstructured":"Lee SP, Lee ES, Choi H et al (2015) 11C-Pittsburgh B PET imaging in cardiac amyloidosis. JACC Cardiovasc Imaging 8:50\u201359","journal-title":"JACC Cardiovasc Imaging"},{"key":"9580_CR151","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","volume":"41","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Vangala D, Semer J et al (2014) Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography. Eur J Nucl Med Mol I 41:1652\u20131662","journal-title":"Eur J Nucl Med Mol I"},{"key":"9580_CR152","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169870","author":"WP Law","year":"2016","unstructured":"Law WP, Wang WY, Moore PT et al (2016) Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. J Nucl Med. doi: 10.2967\/jnumed.115.169870","journal-title":"J Nucl Med"},{"key":"9580_CR153","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-015-0287-0","author":"A Gucht Van Der","year":"2015","unstructured":"Van Der Gucht A, Galat A, Rosso J et al (2015) [18F]-NaF PET\/CT imaging in cardiac amyloidosis. J Nucl Cardiol. doi: 10.1007\/s12350-015-0287-0","journal-title":"J Nucl Cardiol"},{"key":"9580_CR154","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-016-0457-8","author":"C Gagliardi","year":"2016","unstructured":"Gagliardi C, Tabacchi E, Bonfiglioli R et al (2016) Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET\/CT? J Nucl Cardiol. doi: 10.1007\/s12350-016-0457-8","journal-title":"J Nucl Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9580-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-016-9580-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9580-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T12:42:57Z","timestamp":1601037777000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-016-9580-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":154,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["9580"],"URL":"https:\/\/doi.org\/10.1007\/s10741-016-9580-5","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,23]]}}}